«Keloid

Below is an extended Keloid patents listing. Click here to return to the Keloid main in depth entry.

Patents :
US Patent No.	Title
7342029	Substituted indoles
7361346	Therapeutic compositions that produce an immune response
7361647	Analogs of benzoquinone-containing ansamycins and methods of use thereof
7361669	Compositions and method for inhibiting TGF-.beta.
7364565	Controlled enzymatic removal and retrieval of cells
7365072	Inhibitors of p38
7365084	Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
7365158	PR-domain containing nucleic acids, polypeptides, antibodies and methods
7365175	Wit 3.0, a novel gene to control soft tissue wound healing
7368111	Human antibodies specific for TGF.beta.2
7368527	HADDE71 polypeptides
7361185	Clinical and surgical system and method for moving and stretching plastic tissue
7359748	Apparatus for total immersion photography
7358370	Benzene, pyridine, and pyridazine derivatives
7344547	Laparoscopic instruments and trocar systems and related surgical method
7344882	Polynucleotides encoding variants of the TRP channel family member, LTRPC3
7345045	Pyrido-pyrimidine compounds as medicaments
7345148	Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
7348331	Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
7348336	Substituted .beta.-carbolines
7348418	Carcinoma-related genes and polypeptides and methods of use thereof
7354941	Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
7357927	Death domain containing receptors
7358074	Human phosphatase RET31, and variants thereof
7368531	Human secreted proteins
7371377	Antibodies to polypeptides homologous to VEGF and BMP1
7390813	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396533	Polypeptides and nucleic acids encoding same
7396935	Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
7399781	N-substituted benzothiophenesulfonamide derivatives
7399783	Methods for the treatment of scar tissue
7402312	Antibodies to vascular endothelial growth factor 2 (VEGF-2)
7407958	2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
7407973	Use of pirfenidone in therapeutic regimens
7410947	Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
7390656	Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
7390637	Keratinocyte derived interferon
7387271	Immunostimulatory combinations
7371772	Bicyclic compound, production and use thereof
7371822	Human G-protein coupled receptor variant of HM74, HGPRBMY74
7371825	Anti-MCP-1 antibodies, compositions, methods and uses
7375180	Methods and compositions related to IRM compounds and Toll-like receptor 8
7375217	Analogs of benzoquinone-containing ansamycins and methods of use thereof
7378248	In vivo production of cyclic peptides for inhibiting protein-protein interaction
7381800	Antibodies to HBIMF63 polypeptide
7384634	Connective tissue growth factor
7385034	Complementary DNAs encoding proteins with signal peptides
7385036	Human tango 509 polypeptides
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.